Picture of Clearpoint Neuro logo

CLPT Clearpoint Neuro News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Clearpoint Neuro Inc expected to post a loss of 19 cents a share - Earnings Preview

* Clearpoint Neuro Inc  CLPT.OQ   CLPT.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
8. 
    * The Solana Beach California-based  company is expected to
report
 a 18.2% increase in revenue to $5.405 million from $4.57
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Clearpoint Neuro
Inc is
for a loss of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $20.25​, above​ its last closing price of $9.77. ​​​

This summary was machine generated November 4 at 23:20 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Clearpoint Neuro

See all news